• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影像学在罕见的新冠疫苗多器官并发症中的作用

Role of imaging in rare COVID-19 vaccine multiorgan complications.

作者信息

Cau Riccardo, Mantini Cesare, Monti Lorenzo, Mannelli Lorenzo, Di Dedda Emanuele, Mahammedi Abdelkader, Nicola Refky, Roubil John, Suri Jasjit S, Cerrone Giulia, Fanni Daniela, Faa Gavino, Carriero Alessandro, Scuteri Angelo, Francone Marco, Saba Luca

机构信息

Department of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), di Cagliari - Polo di Monserrato, s.s. 554 Monserrato, 09045, Cagliari, Italy.

Department of Neuroscience, Imaging and Clinical Sciences, 'G. d'Annunzio' University, Chieti, Italy.

出版信息

Insights Imaging. 2022 Mar 14;13(1):44. doi: 10.1186/s13244-022-01176-w.

DOI:10.1186/s13244-022-01176-w
PMID:35286509
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8919150/
Abstract

As of September 18th, 2021, global casualties due to COVID-19 infections approach 200 million, several COVID-19 vaccines have been authorized to prevent COVID-19 infection and help mitigate the spread of the virus. Despite the vast majority having safely received vaccination against SARS-COV-2, the rare complications following COVID-19 vaccination have often been life-threatening or fatal. The mechanisms underlying (multi) organ complications are associated with COVID-19, either through direct viral damage or from host immune response (i.e., cytokine storm). The purpose of this manuscript is to review the role of imaging in identifying and elucidating multiorgan complications following SARS-COV-2 vaccination-making clear that, in any case, they represent a minute fraction of those in the general population who have been vaccinated. The authors are both staunch supporters of COVID-19 vaccination and vaccinated themselves as well.

摘要

截至2021年9月18日,因感染新冠病毒导致的全球伤亡人数接近2亿,已有数种新冠疫苗被批准用于预防新冠病毒感染并有助于减缓病毒传播。尽管绝大多数人已安全接种了针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的疫苗,但新冠疫苗接种后罕见的并发症往往危及生命或致命。(多)器官并发症的潜在机制与新冠病毒有关,要么是通过病毒直接损伤,要么是源于宿主免疫反应(即细胞因子风暴)。本手稿的目的是回顾影像学在识别和阐明接种SARS-CoV-2疫苗后多器官并发症方面的作用——明确指出,无论如何,这些并发症在已接种疫苗的普通人群中只占极小一部分。作者都是新冠疫苗接种的坚定支持者,并且自己也接种了疫苗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8370/8921368/1e1c3430103d/13244_2022_1176_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8370/8921368/d309485ac3f2/13244_2022_1176_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8370/8921368/dad9c5f3f564/13244_2022_1176_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8370/8921368/d9d5fcd1b8a8/13244_2022_1176_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8370/8921368/195737b8c897/13244_2022_1176_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8370/8921368/2896c06be91d/13244_2022_1176_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8370/8921368/9d481a6eb19d/13244_2022_1176_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8370/8921368/848e67b26083/13244_2022_1176_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8370/8921368/1e1c3430103d/13244_2022_1176_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8370/8921368/d309485ac3f2/13244_2022_1176_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8370/8921368/dad9c5f3f564/13244_2022_1176_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8370/8921368/d9d5fcd1b8a8/13244_2022_1176_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8370/8921368/195737b8c897/13244_2022_1176_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8370/8921368/2896c06be91d/13244_2022_1176_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8370/8921368/9d481a6eb19d/13244_2022_1176_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8370/8921368/848e67b26083/13244_2022_1176_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8370/8921368/1e1c3430103d/13244_2022_1176_Fig8_HTML.jpg

相似文献

1
Role of imaging in rare COVID-19 vaccine multiorgan complications.影像学在罕见的新冠疫苗多器官并发症中的作用
Insights Imaging. 2022 Mar 14;13(1):44. doi: 10.1186/s13244-022-01176-w.
2
Serious neurological adverse events following immunization against SARS-CoV-2: a narrative review of the literature.2019冠状病毒病疫苗接种后的严重神经系统不良事件:文献综述
Ther Adv Drug Saf. 2023 May 21;14:20420986231165674. doi: 10.1177/20420986231165674. eCollection 2023.
3
Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies.接种 SARS-CoV-2 疫苗后的抗体水平:两项英国纵向研究中与接种后感染和危险因素的关系。
Elife. 2023 Jan 24;12:e80428. doi: 10.7554/eLife.80428.
4
Estimated Number of COVID-19 Infections, Hospitalizations, and Deaths Prevented Among Vaccinated Persons in the US, December 2020 to September 2021.美国 2020 年 12 月至 2021 年 9 月,疫苗接种者预防 COVID-19 感染、住院和死亡人数的估计数。
JAMA Netw Open. 2022 Jul 1;5(7):e2220385. doi: 10.1001/jamanetworkopen.2022.20385.
5
Evaluating risk factors associated with COVID-19 infections among vaccinated people early in the U.S. vaccination campaign: an observational study of five states, January-March 2021.评估美国疫苗接种运动早期接种人群中与 COVID-19 感染相关的风险因素:2021 年 1 月至 3 月五个州的观察性研究。
BMC Infect Dis. 2022 Sep 1;22(1):718. doi: 10.1186/s12879-022-07702-x.
6
SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.SARS-CoV-2 变异株特异性复制 RNA 疫苗可预防同源关切变异株挑战后的疾病。
Elife. 2022 Feb 22;11:e75537. doi: 10.7554/eLife.75537.
7
Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study.与 SARS-CoV-2 感染和卡塔尔严重 COVID-19 相比,先前自然感染的保护作用:一项回顾性队列研究。
Lancet Microbe. 2022 Dec;3(12):e944-e955. doi: 10.1016/S2666-5247(22)00287-7. Epub 2022 Nov 11.
8
An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data.一项针对风湿和免疫介导性疾病患者的阿根廷队列研究:SARS-CoV-2 疫苗接种:SAR-CoVAC 注册研究方案和初步数据。
Clin Rheumatol. 2022 Oct;41(10):3199-3209. doi: 10.1007/s10067-022-06253-5. Epub 2022 Jun 28.
9
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.全面描述了针对 SARS-CoV-2 刺突蛋白的抗体反应,发现了除轻度感染诱导的表位之外的其他疫苗诱导的表位。
Elife. 2022 Jan 24;11:e73490. doi: 10.7554/eLife.73490.
10
Community risks for SARS-CoV-2 infection among fully vaccinated US adults by rurality: A retrospective cohort study from the National COVID Cohort Collaborative.美国农村地区完全接种疫苗的成年人中 SARS-CoV-2 感染的社区风险:来自国家 COVID 队列协作的回顾性队列研究。
PLoS One. 2023 Jan 5;18(1):e0279968. doi: 10.1371/journal.pone.0279968. eCollection 2023.

引用本文的文献

1
Impact, Trends, and Visibility of Scientific Publications on Neurological Effects of COVID-19 Vaccine: A Scientometric Analysis.关于新冠疫苗神经学效应的科学出版物的影响力、趋势及可见性:一项科学计量分析
J Glob Infect Dis. 2025 Jun 26;17(2):98-103. doi: 10.4103/jgid.jgid_159_24. eCollection 2025 Apr-Jun.
2
Blood Coagulation and Thrombotic Disorders following SARS-CoV-2 Infection and COVID-19 Vaccination.新型冠状病毒2感染和新冠疫苗接种后的血液凝固及血栓形成障碍
Biomedicines. 2023 Oct 17;11(10):2813. doi: 10.3390/biomedicines11102813.
3
Post-COVID-19 Vaccination CNS Magnetic Resonance Imaging Findings: A Systematic Review.

本文引用的文献

1
Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study.描述 8 个国家/地区新冠病毒疫苗特殊关注不良事件的背景发生率:跨国网络队列研究。
BMJ. 2021 Jun 14;373:n1435. doi: 10.1136/bmj.n1435.
2
Myocarditis following COVID-19 mRNA vaccination.新冠病毒mRNA疫苗接种后的心肌炎
Proc (Bayl Univ Med Cent). 2021 Nov 15;35(2):209-213. doi: 10.1080/08998280.2021.1990743. eCollection 2022.
3
Attention all anti-vaccinators: The cutaneous adverse events from the mRNA COVID-19 vaccines are not an excuse to avoid them!
新冠病毒感染后疫苗接种的中枢神经系统磁共振成像结果:一项系统综述
Can J Infect Dis Med Microbiol. 2023 Jun 29;2023:1570830. doi: 10.1155/2023/1570830. eCollection 2023.
4
Segmentation-Based Classification Deep Learning Model Embedded with Explainable AI for COVID-19 Detection in Chest X-ray Scans.基于分割的分类深度学习模型,嵌入可解释人工智能用于胸部X光扫描中的新冠肺炎检测
Diagnostics (Basel). 2022 Sep 2;12(9):2132. doi: 10.3390/diagnostics12092132.
5
COVLIAS 2.0-cXAI: Cloud-Based Explainable Deep Learning System for COVID-19 Lesion Localization in Computed Tomography Scans.COVLIAS 2.0-cXAI:用于计算机断层扫描中新冠病毒病变定位的基于云的可解释深度学习系统。
Diagnostics (Basel). 2022 Jun 16;12(6):1482. doi: 10.3390/diagnostics12061482.
所有反疫苗接种者请注意:mRNA COVID-19 疫苗的皮肤不良反应并不是回避接种它们的理由!
Clin Dermatol. 2021 Jul-Aug;39(4):674-687. doi: 10.1016/j.clindermatol.2021.05.027. Epub 2021 May 21.
4
Review of imaging biomarkers for the vulnerable carotid plaque.易损性颈动脉斑块的影像学生物标志物综述。
JVS Vasc Sci. 2021 May 15;2:149-158. doi: 10.1016/j.jvssci.2021.03.001. eCollection 2021.
5
Acute Myocardial Infarction Within 24 Hours After COVID-19 Vaccination.接种新冠疫苗 24 小时内发生急性心肌梗死。
Am J Cardiol. 2021 Oct 1;156:129-131. doi: 10.1016/j.amjcard.2021.06.047. Epub 2021 Jul 12.
6
Purpuric Skin Rash in a Patient Undergoing Pfizer-BioNTech COVID-19 Vaccination: Histological Evaluation and Perspectives.一名接种辉瑞-生物科技公司新冠疫苗的患者出现紫癜性皮疹:组织学评估及观点
Vaccines (Basel). 2021 Jul 8;9(7):760. doi: 10.3390/vaccines9070760.
7
Lymphadenopathy after the Anti-COVID-19 Vaccine: Multiparametric Ultrasound Findings.抗COVID-19疫苗接种后的淋巴结病:多参数超声检查结果
Biology (Basel). 2021 Jul 12;10(7):652. doi: 10.3390/biology10070652.
8
Vaccine-induced severe thrombotic thrombocytopenia following COVID-19 vaccination: a report of an autoptic case and review of the literature.接种 COVID-19 疫苗后疫苗诱导的严重血栓性血小板减少症:1 例尸检病例报告及文献复习。
Eur Rev Med Pharmacol Sci. 2021 Aug;25(15):5063-5069. doi: 10.26355/eurrev_202108_26464.
9
Cardiovascular Adverse Events Reported from COVID-19 Vaccines: A Study Based on WHO Database.新冠疫苗报告的心血管不良事件:一项基于世界卫生组织数据库的研究
Int J Gen Med. 2021 Jul 27;14:3909-3927. doi: 10.2147/IJGM.S324349. eCollection 2021.
10
Myocarditis Following COVID-19 Vaccination.新冠疫苗接种后的心肌炎
Radiology. 2021 Oct;301(1):E378-E379. doi: 10.1148/radiol.2021211766. Epub 2021 Aug 3.